Back
Collegium Pharmaceutical Vs. Context Therapeutics Industry Stock Comparison
Buy
70
COLL
Collegium Pharmaceutical
Last Price:
39.12
Seasonality Move:
31.73%
Buy
66
CNTX
Context Therapeutics
Last Price:
2.26
Seasonality Move:
-23.73%
Buy
70
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $39.10. The Score for COLL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Context Therapeutics (CNTX)
is a Buy
Is Context Therapeutics a Buy, Sell or Hold?
- The current Context Therapeutics [CNTX] share price is $2.25. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CNTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $39.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing slight buying pressure.
CNTX Stock Price Chart
What is Context Therapeutics's stock price today?
-
The Context Therapeutics share price today is $2.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNTX is experiencing selling pressure, which indicates risk of future bearish movement.
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.67 | Buy |
Relative Strength Index (14 RSI): | 63.12 | Buy |
Chaikin Money Flow: | 281480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.13 - 38.25) | Buy |
Bollinger Bands (100): | (32.2 - 37.06) | Buy |
CNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 49.85 | Sell |
Chaikin Money Flow: | -385854 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.15 - 2.51) | Sell |
Bollinger Bands (100): | (1.83 - 2.37) | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.69 | Buy |
20-day SMA: | 37.53 | Buy |
50-day SMA: | 35.96 | Buy |
200-day SMA: | 34.48 | Buy |
8-day EMA: | 38.07 | Buy |
20-day EMA: | 37.39 | Buy |
50-day EMA: | 36.24 | Buy |
200-day EMA: | 33.42 | Buy |
CNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.12 | Buy |
20-day SMA: | 2.28 | Sell |
50-day SMA: | 2.3 | Sell |
200-day SMA: | 1.63 | Buy |
8-day EMA: | 2.16 | Buy |
20-day EMA: | 2.23 | Buy |
50-day EMA: | 2.23 | Buy |
200-day EMA: | 1.79 | Buy |
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.10 per share, an increase this year of $0.99 per share, and an increase next year of $0.44 per share.
Context Therapeutics Earnings Growth & CNTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
Collegium Pharmaceutical Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Context Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |